I am interested in ID-alG TM, please contact me.Contact
(93001) Clinical study (2006): 16-weeks bi-centric double-blind randomized placebo-controlled study to evaluate ID-alG benefits and acceptability (400mg per day) on weight management
(93002) Evaluation of IG-alGTM’s weight management effect on overweight women. Monocentric, randomized, placebo controlled clinical study run in March 2010, on 56 women using 400 mg of ID-alGTM daily for 8 weeks.
This communication is not intended to the final consumer. It provides scientific information for professionals only. Communications to the final consumer have to be checked according to local regulations in force, since the conditions of use are beyond our control. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.